-
2025-520715-13-00
Idiopathic Pulmonary Fibrosis 4 2026-04-22
-
2025-523234-66-00
Well-Controlled Recurrent Pericarditis 4 2026-04-17
-
2024-517279-20-02
Cardiac arrest 4 2026-04-14
-
2025-521792-31-01
Homozygous Familial Hypercholesterolemia (HoFH) 5 2026-04-07
-
2024-518705-18-00
Degree of control coronary risk factors and platelet ag 11 2026-03-27
-
2024-512436-29-00
CARDIOVASCULAR DISEASES 11 2026-03-27
-
2024-515635-30-00
Coagulopathy 3 2026-03-24
-
2024-511985-34-00
Evaluation of the CKD-Epi score to identify a glomerula 6 2026-03-05
-
2025-521408-24-00
Fabry disease 5 2026-03-05
-
2025-522553-19-00
Symptomatic genetic and familial dilated cardiomyopathy 10 2026-02-25
-
2025-521831-35-00
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) 6 2026-02-12
-
2024-519068-42-00
Heterozygous Familial Hypercholesterolemia in pediatr 10 2026-02-12
-
2024-519674-40-00
BAG3 Mutation Associated Dilated Cardiomyopathy 7 2026-02-05
-
2024-519706-13-00
Patients with Stable or Unstable coronary syndromes who 6 2026-01-26
-
2024-518899-31-00
Variant or wild-type transthyretin (TTR) amyloid cardio 5 2025-12-19
-
2025-521780-12-00
Non-ischemic cardiomyopathy 11 2025-12-16
-
2025-520794-39-00
Arterial Hypertension 5 2025-12-10
-
2024-516188-10-00
Intracerebral haemorrhage 6 2025-10-07
-
2024-519551-29-00
Acute cerebral ischemic stroke 5 2025-08-21
-
2024-516646-19-00
Type 2 diabetic patients with no prior cardiovascular ( 5 2025-08-15
-
2024-510682-42-01
Andersen-Tawil syndrome 6 2025-08-13
-
2024-514595-41-00
homozygous familial hypercholesterolemia 5 2025-08-05
-
2025-521179-29-00
Chronic subdural hematoma 10 2025-07-06
-
2024-519356-87-00
Dialysis Heart failure 6 2025-06-13